Lab of the Future USA
The Boston Park Plaza

Vectura speaks on “Navigating software changes with confidence: don’t fear your updates!”

Digitize and contextualize R&D data capture at the point of work in a secure data backbone

With new biologics generally taking a decade or more to bring to market, there’s an urgent need to improve the overall efficiency and cost-effectiveness of BioPharma development. Organizations entrust their digital tools to bring them the operational efficiencies, compliant data capture and timely insight they need, to deliver life-changing drugs to market.

At IDBS, we understand the importance of productivity, efficiency, and compliance across the product lifecycle, and empower our customers to unlock the power of data for faster and smarter decision making. Designed and deployed with our customers’ mission front and center, we ensure the IDBS platform offers true digital transformation success – allowing BioPharma organizations to focus on cutting edge science.

Join our customer Vectura, a leading inhaler specialist CDMO, as they share their experience and best practices on “Navigating software changes with confidence: don’t fear your updates” presented by David Thomas, Analytics Manager at Vectura, and joined by Jim Brooks, Lead Platform Product Manager, GxP Strategy at IDBS.

As Pharma organizations charge ahead with their digital transformation endeavors, they often run into hurdles and resistance when it comes to software updates and upgrades. Though software updates are an inevitable part of the digitization journey, they don’t have to be painful. There is incredible value to organizations to perform these at regular intervals; from allowing for manageable amounts of quality and validation effort, to being able to confidently anticipate changes to business processes and policies.

Join David Thomas as he shares Vectura’s approach to streamlining successful updates to their SaaS data management platform, IDBS E-WorkBook – compliantly testing software changes, mitigating risks, reducing potential downtimes and minimally impacting business continuity and highlighting key aspects to facilitate successful validation of both system and workflow updates – all in a GMP CDMO organization.

Watch the presentation on-demand below.

If you’d like to learn more, read this article by Jim Brooks on “How to improve time-to-value using GxP computer systems.

Meet our speakers

David Thomas, Analytics Manager, Vectura

David Thomas is the Manager of the Analytics department at Vectura, leading lab-based hardware and software infrastructure projects. He has managed Vectura’s digital lab system and digital transformation strategy since its launch at Vectura’s first site, continuing through implementation into new departments and sites across Vectura.

David has a background in Chemistry with a MChem Degree from the University of Manchester. Prior to his involvement and assuming leadership of Vectura’s digital lab system deployment, he spent 8 years working as a Scientist at Vectura, specializing in physical properties characterization.

Jim Brooks, Lead Platform Product Manager, GxP Strategy, IDBS

Jim Brooks is the Lead Platform Product Manager for GxP Strategy at IDBS. In this role, he is accountable for defining and delivering initiatives focused on assisting customers in achieving and maintaining compliance with applicable GxP computerized system regulations. His long-standing career spans over 20 years in BioPharma, including roles in QC, QA and IT where he was responsible for validating, deploying and managing laboratory information systems in GxP-regulated environments.

Meet the team

Michael Killen Director North America Sales

Michael Killeen, Director, North America Sales, IDBS

Michael joined IDBS in October of 2023 and with over 35 years in the biotech/biopharma industry, leads the North American Sales Team.  

Prior to IDBS, he spent 12+ years at Cytiva as a Global Strategic Account Director. Before joining Cytiva, most of his career was spent at Sartorius and Pall where he held positions in a variety of commercial roles. 

Melanie Juba Head of Product Management BioPharma

Melanie Juba, Head of Product Management – BioPharma, IDBS

Melanie is Head of Product Management, where she leads the global product strategy, roadmap and innovation.  

Melanie has been part of the Danaher family for nine years, working at Sciex where she started in the applications team, focusing on solving customer challenges in BioPharma and omics workflows. She then held a variety of roles across the organization, including the commercial sales team and BioPharma business unit driving market growth in the life sciences markets through direct sales, marketing and product management.  

Melanie has a PhD in Chemistry & Biochemistry from George Mason University where she worked on physico-chemical characterization and mass spectral identification of therapeutic proteins. To further her knowledge of mass spectrometry in other biological applications she continued on to do a post-doc.

Fi Rich Global Strategic Account Manager

Fi Rich, Senior Account Manager, IDBS

Fi has been with IDBS for two years and is responsible for supporting BioPharma, CRO and CDMO customers in reaching their digital and data strategy goals.  

Prior to IDBS, Fi spent over 20 years on the commercial side of Pharmaceuticals, MedTech and System Integration with several companies including J&J, Baxter and Olympus Medical. Gaining diverse experience from marketing and professional education to P&L responsibilities and mergers and acquisitions, Fi can help clients navigate various business challenges to help achieve their program improvements through optimized change management. 

She has a degree in Applied Sciences from Nottingham Trent University.  

About Lab of the Future USA: Join hundreds of life science research leaders for the most innovative and best-attended congress on the future of BioPharma R&D.

At the Lab of the Future, they take time and effort to collate different experiences, knowledge and viewpoints around pertinent topics and ensure sessions are well moderated leading to insightful discussion and the generation of new ideas.

More webinars